Fibroses, Pulmonary
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19 (NCT04645368) | NPO Petrovax | 2020-07-01 |
Track Fibroses, Pulmonary automatically
Every clearance here is in the API, with alerts when new ones post.